AI helps surgeons spot skin cancer cells during surgery

NCT ID NCT06600165

Recruiting now Knowledge-focused Sponsor: LMU Klinikum Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether artificial intelligence (AI) can help surgeons analyze microscope images of skin cancer tissue during surgery. The goal is to give surgeons real-time feedback so they can remove all cancer cells in one go. The trial will enroll 1,000 people with basal cell carcinoma, a common skin cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a tool that helps surgeons remove skin cancer more completely in a single surgery, reducing the need for repeat procedures.
What could go wrong: This is an early-stage study focused on developing and testing the AI tool, not yet proving it improves patient outcomes. The technology may not work as well in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

basal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BASAL CELL CARCINOMA

Contacts and locations

Locations

Clinic and Policlinic of Dermatology and Allergy, LMU Munich
RECRUITING

Munich, Bavaria, 80337, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.